Search Results - "Vejpongsa, Pimprapa"

Prevention of Anthracycline-Induced Cardiotoxicity by Vejpongsa, Pimprapa, MD, Yeh, Edward T.H., MD

“…Abstract Anthracycline compounds are major culprits in chemotherapy-induced cardiotoxicity, which is the chief limiting factor in delivering optimal…”
Get full text

Long term development of diastolic dysfunction and heart failure with preserved left ventricular ejection fraction in heart transplant recipients by Vejpongsa, Pimprapa, Torre-Amione, Guillermo, Marcos-Abdala, Hernan G., Kumar, Salil, Youker, Keith, Bhimaraj, Arvind, Nagueh, Sherif F.

“…Heart transplant recipients (HTX) have several risk factors for heart failure which can trigger pro-inflammatory and fibrosis factors and set into motion…”
Get full text

Comparison of Echocardiographic Assessment of Tricuspid Regurgitation Against Cardiovascular Magnetic Resonance by Zhan, Yang, Senapati, Alpana, Vejpongsa, Pimprapa, Xu, Jiaqiong, Shah, Dipan J., Nagueh, Sherif F.

“…The aim of this study was to compare echocardiographic methods of determining tricuspid regurgitation (TR) severity against TR regurgitant volume (TRRV) by…”
Get full text

Subclinical Cardiotoxicity Associated With Cancer Therapy by Yeh, Edward T.H., MD, Vejpongsa, Pimprapa, MD

“…Compared with siblings, cancer survivors are 10 times more likely to develop coronary disease and 15 times more likely to develop heart failure (HF) (2)…”
Get full text

Takotsubo Stress Cardiomyopathy by Munoz, Ezequiel, MD, Iliescu, Gloria, MD, Vejpongsa, Pimprapa, MD, Charitakis, Konstantinos, MD, Karimzad, Kaveh, MD, Lopez-Mattei, Juan, MD, Yusuf, Syed Wamique, MD, Marmagkiolis, Konstantinos, MD, Iliescu, Cezar, MD

Get full text

Epstein-Barr Virus-Related Hemophagocytic Lymphohistiocytosis: Hematologic Emergency in the Critical Care Setting by Chen, Lei, Baljevic, Muhamed, Vejpongsa, Pimprapa, Hashemi-Sadraei, Neda, Idowu, Modupe

“…Hemophagocytic lymphohistiocytosis (HLH) is a rare and potential life-threatening clinical syndrome that results from uncontrolled activation of the immune…”
Get full text

Prevention of Anthracycline-Induced Cardiotoxicity: Challenges and Opportunities by VEJPONGSA, Pimprapa, YEH, Edward T. H

“…Anthracycline compounds are major culprits in chemotherapy-induced cardiotoxicity, which is the chief limiting factor in delivering optimal chemotherapy to…”
Get full text

Outcomes of Acute Myocardial Infarction in Patients with Influenza and Other Viral Respiratory Infections by Vejpongsa, Pimprapa, Kitkungvan, Danai, Madjid, Mohammad, Charitakis, Konstantinos, Anderson, H. Vernon, Arain, Salman, Balan, Prakash, Smalling, Richard W., Dhoble, Abhijeet

“…Acute influenza infection can trigger acute myocardial infarction, however, outcome of patients with acute myocardial infarction during influenza infection is…”
Get full text

Emerging Paradigms in Cardiomyopathies Associated With Cancer Therapies by Ky, Bonnie, Vejpongsa, Pimprapa, Yeh, Edward T.H., Force, Thomas, Moslehi, Javid J.

“…The cardiovascular care of cancer patients (cardio-oncology) has emerged as a new discipline in clinical medicine, given recent advances in cancer therapy, and…”
Get full text

Differences in Cardiac Remodeling in Left-Sided Valvular Regurgitation: Implications for Optimal Definition of Significant Aortic Regurgitation by Vejpongsa, Pimprapa, Xu, Jiaqiong, Quinones, Miguel A, Shah, Dipan J, Zoghbi, William A

“…BACKGROUNDGrading of aortic regurgitation (AR) and mitral regurgitation (MR) is similar in the cardiology guidelines despite distinct differences in left…”
Get full text

Subclinical Cardiotoxicity Associated With Cancer Therapy: Early Detection and Future Directions by Yeh, Edward T.H., Vejpongsa, Pimprapa

Get full text

Differences in Cardiac Remodeling in Left-Sided Valvular Regurgitation by Vejpongsa, Pimprapa, Xu, Jiaqiong, Quinones, Miguel A., Shah, Dipan J., Zoghbi, William A.

Get full text

THE DIFFERENCE IN CARDIAC REMODELING IN LEFT-SIDED VALVULAR REGURGITATION: IMPLICATIONS FOR THE OPTIMAL DEFINITION OF SEVERE AORTIC REGURGITATION by Vejpongsa, Pimprapa, Xu, Susan, Quinones, Miguel A., Shah, Dipan J., Zoghbi, William

Get full text

Takotsubo Stress Cardiomyopathy: “Good News” in Cancer Patients? by Munoz, Ezequiel, Iliescu, Gloria, Vejpongsa, Pimprapa, Charitakis, Konstantinos, Karimzad, Kaveh, Lopez-Mattei, Juan, Yusuf, Syed Wamique, Marmagkiolis, Konstantinos, Iliescu, Cezar

“…In the present study, we compared mortality in cancer patients with TSC with non-ST-segment elevation myocardial infarction (NSTEMI) as a control group…”
Get full text

Stress-Induced Cardiomyopathy in Cancer Patients by Giza, Dana Elena, Lopez-Mattei, Juan, Vejpongsa, Pimprapa, Munoz, Ezequiel, Iliescu, Gloria, Kitkungvan, Danai, Hassan, Saamir A., Kim, Peter, Ewer, Michael S., Iliescu, Cezar

“…Takotsubo syndrome, also known as stress-induced cardiomyopathy (SC), is underrecognized in cancer patients. This study aims to investigate the incidence,…”
Get full text

Echocardiographic Evaluation of Hemodynamics in Heart Transplant Recipients by Vejpongsa, Pimprapa, Marcos-Abdala, Hernan G., Bhimaraj, Arvind, Nagueh, Sherif F.

Get full text

National 10-year trends and outcomes of isolated and concomitant tricuspid valve surgery by Dhoble, Abhijeet, Zhao, Yelin, Vejpongsa, Pimprapa, Loghin, Catalin, Smalling, Richard W, Estrera, Anthony, Nguyen, Tom C

“…The data on the trends and comparative outcomes after isolated and concomitant tricuspid valve repair/replacement (TVR) is scarce. The International…”
Get full text

QT INTERVAL AND CARDIAC EVENTS IN CANCER PATIENTS: AN ANALYSIS OF MD ANDERSON ECG DATABASE FROM 2009-2012 by Vejpongsa, Pimprapa, Kitkungvan, Danai, Kim, Peter

Get full text

RISK, CAUSES AND OUTCOMES OF EARLY READMISSIONS AFTER TRICUSPID VALVE SURGERY by Dhoble, Abhijeet, Vejpongsa, Pimprapa, Loghin, Catalin, Smalling, Richard, Estrera, Anthony L., Nguyen, Tom

Get full text

ENDOCARDITIS IN CANCER PATIENTS WITH AND WITHOUT THROMBOCYTOPENIA: PREVALENCE AND COMPLICATION RATES by Kitkungvan, Danai, Vejpongsa, Pimprapa, Yusuf, Syed, Adachi, Javier, Banchs, Jose

“…Among patients with definite IE, coagulase-negative staphylococcus (28.1%) was the most common pathogen in patient with thrombocytopenia while S. aureus…”
Get full text